ArticleOncology letters2019

Selectively high efficacy of eribulin against high-grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Yutaka Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.